Share Email Print
cover

Proceedings Paper • Open Access

Breast imaging with the SoftVue imaging system: first results
Author(s): Neb Duric; Peter Littrup; Steven Schmidt; Cuiping Li; Olivier Roy; Lisa Bey-Knight; Roman Janer; Dave Kunz; Xiaoyang Chen; Jeffrey Goll; Andrea Wallen; Fouzaan Zafar; Veerendra Allada; Erik West; Ivana Jovanovic; Kuo Li; William Greenway

Paper Abstract

For women with dense breast tissue, who are at much higher risk for developing breast cancer, the performance of mammography is at its worst. Consequently, many early cancers go undetected when they are the most treatable. Improved cancer detection for women with dense breasts would decrease the proportion of breast cancers diagnosed at later stages, which would significantly lower the mortality rate. The emergence of whole breast ultrasound provides good performance for women with dense breast tissue, and may eliminate the current trade-off between the cost effectiveness of mammography and the imaging performance of more expensive systems such as magnetic resonance imaging. We report on the performance of SoftVue, a whole breast ultrasound imaging system, based on the principles of ultrasound tomography. SoftVue was developed by Delphinus Medical Technologies and builds on an early prototype developed at the Karmanos Cancer Institute. We present results from preliminary testing of the SoftVue system, performed both in the lab and in the clinic. These tests aimed to validate the expected improvements in image performance. Initial qualitative analyses showed major improvements in image quality, thereby validating the new imaging system design. Specifically, SoftVue’s imaging performance was consistent across all breast density categories and had much better resolution and contrast. The implications of these results for clinical breast imaging are discussed and future work is described.

Paper Details

Date Published: 29 March 2013
PDF: 8 pages
Proc. SPIE 8675, Medical Imaging 2013: Ultrasonic Imaging, Tomography, and Therapy, 86750K (29 March 2013); doi: 10.1117/12.2002513
Show Author Affiliations
Neb Duric, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Peter Littrup, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Steven Schmidt, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Cuiping Li, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Olivier Roy, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Lisa Bey-Knight, Karmanos Cancer Institute (United States)
Delphinus Medical Technologies, Inc. (United States)
Roman Janer, Delphinus Medical Technologies, Inc. (United States)
Dave Kunz, Delphinus Medical Technologies, Inc. (United States)
Xiaoyang Chen, Delphinus Medical Technologies, Inc. (United States)
Jeffrey Goll, Delphinus Medical Technologies, Inc. (United States)
Andrea Wallen, Delphinus Medical Technologies, Inc. (United States)
Fouzaan Zafar, Delphinus Medical Technologies, Inc. (United States)
Veerendra Allada, Delphinus Medical Technologies, Inc. (United States)
Erik West, Delphinus Medical Technologies, Inc. (United States)
Ivana Jovanovic, Delphinus Medical Technologies, Inc. (United States)
Kuo Li, Delphinus Medical Technologies, Inc. (United States)
William Greenway, Delphinus Medical Technologies, Inc. (United States)


Published in SPIE Proceedings Vol. 8675:
Medical Imaging 2013: Ultrasonic Imaging, Tomography, and Therapy
Johan G. Bosch; Marvin M. Doyley, Editor(s)

© SPIE. Terms of Use
Back to Top